Endotherm Wissenschaftliche Publikationen
2020
Putkaradze N, König L, Kattner L, Hutter MC, Bernhardt R: Highly regio- and stereoselective hydroxylation of vitamin D2 by CYP109E1. Biochem Biophys Res Commun 2020;524(2):295-300. doi.org/10.1016/j.bbrc.2020.01.091
2019
Mäder P: Boron in Medicinal Chemistry: Powerful, but Neglected. Chimia 2019;73: 637–638.
Kattner L, Rauch E: Recent developments towards the synthesis of vitamin D metabolites. Anticancer Res 2019;39:3280-3281.
2018
Mohamed BA, Hartmann N, Tirilomis P, Sekeres K, Li W, Neef S, Richter C, Zeisberg EM, Kattner L, Didié M, Guan K, Schmitto JD, Lehnart SE, Luther S, Voigt N, Seidler T, Sossalla S, Hasenfuss G, Toischer K: Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression. Science Translational Medicine 2018;10:eaan0724. DOI: 10.1126/scitranslmed.aan0724
2017
Mohamed, BA, Kattner, L, Guan, K, Lehnart, SE, Luther, S, Sossalla, S, et al.: The relevant role of SR Ca leak in the development of heart failure. European Journal of Heart Failure 2017; 19(Suppl_1): 343-343.
Kattner L, Bernardi D: An Efficient Synthesis of 1,25-Dihydroxyvitamin D3 LC-Biotin. J Steroid Biochem Mol Biol. 2017;173:89-92.
Kattner L, Volmer DA: Synthesis of Low Abundant Vitamin D Metabolites and Assaying Their Distribution in Human Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as a New Tool for Diagnosis and Risk Prediction of Vitamin D related Diseases In: Gowder S, editor. A Critical Evaluation of Vitamin D - Basic Overview, Intech publishers, Rijeka. 2017;103-127. ISBN 978-953-51-3084-0.
2016
Kattner L and Rauch E: Optimization of Chemical Syntheses of Vitamin D C3-Epimers
Anticancer Res 2016;36(3):1417-1422
2015
Kattner L, Rauch E: Optimization of Chemical Syntheses of Vitamin D C3-Epimers Anticancer Res 2015;35:3599-3614
Kattner L, Bernardi D, Rauch E: Development of Efficient Chemical Syntheses of Vitamin D Degradation Products Anticancer Res 2015;35(2):1205-1210
2014
Azimi Hashemi N, Erbguth K, Vogt A, Riemensperger T, Rauch E, Woodmansee D, Nagpal J, Brauner M, Sheves M, Fiala A, Kattner L, Trauner D, Hegemann P, Gottschalk A & Liewald JF: Synthetic retinal analogues modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic tools
Nature Communications 2014;(5):1-12
2013
Sotoud H, Gribbon P, Ellinger B, Reinshagen J, Boknik P, Kattner L, El-Armouche A and Eschenhagen T: Development of a Colorimetric and a Fluorescence Phosphatase-Inhibitor Assay Suitable for Drug Discovery Approaches J Biomol Screen 2013;18(8):899-909
Bourgonje VJ, Vos MA, Ozdemir S, Doisne N, Acsai K, Varro A, Sztojkov-Ivanov A, Zupko I, Rauch E, Kattner L, Bito V, Houtman M, van der Nagel R, Beekman JD, van Veen TA, Sipido K, Antoons G:Combined Na+/Ca2+ Exchanger and L-Type Calcium Channel Block as a Potential Strategy to Suppress Arrhythmias and Maintain Ventricular Function Circ Arrhythm Electrophysiol. 2013;6:371-379
Scholz T, Heyl CL, Bernardi D, Zimmermann S, Kattner L,Klein CD: Chemical, Biochemical and Microbiological Properties of a Brominated Nitrovinylfuran with Broad-Spectrum Antibacterial Activity Bioorg Med Chem, 2013;21:795-804
2009
Steuer C, Heinonen KH, Kattner L, Klein CD: Optimization of Assay Conditions for Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents J. Biomol Screen. 2009;14(9):1102-1108
2008
Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW: Identification of Terfenadine as an Inhibitor of Human
CD81-receptor HCV-E2 Interaction: Synthesis and Structure Optimization Molecules. 2008;13:1081-1110
2007
Kattner L: Outsourcing of medicinal chemistry in the drug discovery process faces CRO´s and pharmaceutical companies with challenges PharmChem. 2007, July/August, 6-7